Clinical Trial Update: Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 study assessing the efficacy and safety of Qinbudan as adjunct therapy for retreatment pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Qinbudan

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED